Philip Morris International Inc.

For the transition period from to Commission File Number 001-33708 Philip Morris International Inc.

677 Washington Blvd, Suite 1100 Stamford Connecticut 06901 (Address of principal executive offices) (Zip Code)

Registrant's telephone number, including area code (203) 905-2410

Former name, former address and former fiscal year, if changed since last report

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No ¨

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes þ No ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No þ At July 17, 2026, there were 1,558,613,439 shares outstanding of the registrant's common stock, no par value per share.

PHILIP MORRIS INTERNATIONAL INC. TABLE OF CONTENTS

Item 1. Financial Statements (Unaudited)

Condensed Consolidated Statements of Earnings for the Six Months Ended June 30, 2026 and 2025 3 Three Months Ended June 30, 2026 and 2025 3

Condensed Consolidated Statements of Comprehensive Earnings for the Six Months Ended June 30, 2026 and 2025 4 Three Months Ended June 30, 2026 and 2025 5

Condensed Consolidated Balance Sheets at June 30, 2026 and December 31, 2025 6 - 7

Condensed Consolidated Statements of Cash Flows for the Six Months Ended June 30, 2026 and 2025 8 - 9

Condensed Consolidated Statements of Stockholders' (Deficit) Equity for the Six Months Ended June 30, 2026 and 2025 10 Three Months Ended June 30, 2026 and 2025 11

Notes to Condensed Consolidated Financial Statements 12 - 40

Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations 41 - 88

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 89